Skip to main content
Top
Published in: BMC Infectious Diseases 1/2012

Open Access 01-12-2012 | Research article

R-848 triggers the expression of TLR7/8 and suppresses HIV replication in monocytes

Authors: Hua Nian, Wen-Qing Geng, Hua-Lu Cui, Ming-jia Bao, Zi-ning Zhang, Min Zhang, Ying Pan, Qing-Hai Hu, Hong Shang

Published in: BMC Infectious Diseases | Issue 1/2012

Login to get access

Abstract

Background

Toll-like receptors (TLR) 7 and 8 are important in single-stranded viral RNA recognition and may play a role in HIV infection and disease progression. We analyzed TLR7/8 expression and signaling in monocytes from HIV-infected and uninfected subjects to investigate a pathway with new potential for the suppression of HIV replication.

Methods

Eighty-one HIV-infected and uninfected subjects from Liaoning and Henan provinces in China participated in this study. Monocytes were isolated from subjects' peripheral blood mononuclear cells by magnetic bead selection. TLR7 and TLR8 mRNA was measured using quantitative real-time reverse transcriptase PCR. R-848 (resiquimod) was used as a ligand for TLR7 and TLR8 in order to 1) assess TLR7/8-mediated monocyte responsiveness as indicated by IL-12 p40 and TNF-α secretion and 2) to examine HIV replication in cultured monocytes in the presence of R-848.

Results

We found that expression of TLR7/8 mRNA in peripheral blood monocytes decreased with disease progression. TLR7 expression was decreased with stimulation with the TLR7/8 agonist, R-848, in vitro, whereas TLR8 expression was unaffected. Following R-848 stimulation, monocytes from HIV-infected subjects produced significantly less TNF-α than those from uninfected subjects, but trended towards greater production of IL-12 than stimulated monocytes from uninfected subjects. R-848 stimulation also suppressed HIV replication in cultured monocytes.

Conclusions

Our study provides evidence that the TLR7 and TLR8 triggering can suppress HIV replication in monocytes and lead to postpone HIV disease progression, thereby offering novel targets for immunomodulatory therapy.
Appendix
Available only for authorised users
Literature
1.
go back to reference Levy JA: The importance of the innate immune system in controlling HIV infection and disease. Trends in immunology. 2001, 22: 312-316. 10.1016/S1471-4906(01)01925-1.CrossRefPubMed Levy JA: The importance of the innate immune system in controlling HIV infection and disease. Trends in immunology. 2001, 22: 312-316. 10.1016/S1471-4906(01)01925-1.CrossRefPubMed
2.
go back to reference Lehner T: Innate and adaptive mucosal immunity in protection against HIV infection. Vaccine. 2003, 21 (Suppl 2): S68-S76.CrossRefPubMed Lehner T: Innate and adaptive mucosal immunity in protection against HIV infection. Vaccine. 2003, 21 (Suppl 2): S68-S76.CrossRefPubMed
3.
go back to reference Siegal FP, Spear GT: Innate immunity and HIV. AIDS (London, England). 2001, Suppl 5 (5): 127-13.CrossRef Siegal FP, Spear GT: Innate immunity and HIV. AIDS (London, England). 2001, Suppl 5 (5): 127-13.CrossRef
4.
go back to reference Takeda K, Kaisho T, Akira S: Toll-like receptors. Annu Rev Immunol. 2003, 21: 335-376. 10.1146/annurev.immunol.21.120601.141126.CrossRefPubMed Takeda K, Kaisho T, Akira S: Toll-like receptors. Annu Rev Immunol. 2003, 21: 335-376. 10.1146/annurev.immunol.21.120601.141126.CrossRefPubMed
5.
go back to reference Barton GM: Viral recognition by Toll-like receptors. Semin Immunol. 2007, 19: 33-40. 10.1016/j.smim.2007.01.003.CrossRefPubMed Barton GM: Viral recognition by Toll-like receptors. Semin Immunol. 2007, 19: 33-40. 10.1016/j.smim.2007.01.003.CrossRefPubMed
6.
go back to reference Pasare C, Medzhitov R: Toll-like receptors: linking innate and adaptive immunity. Adv Exp Med Biol. 2005, 560: 11-18. 10.1007/0-387-24180-9_2.CrossRefPubMed Pasare C, Medzhitov R: Toll-like receptors: linking innate and adaptive immunity. Adv Exp Med Biol. 2005, 560: 11-18. 10.1007/0-387-24180-9_2.CrossRefPubMed
7.
go back to reference Kumar H, Kawai T, Akira S: Toll-like receptors and innate immunity. Biochem Biophys Res Commun. 2009, 388: 621-625. 10.1016/j.bbrc.2009.08.062.CrossRefPubMed Kumar H, Kawai T, Akira S: Toll-like receptors and innate immunity. Biochem Biophys Res Commun. 2009, 388: 621-625. 10.1016/j.bbrc.2009.08.062.CrossRefPubMed
8.
go back to reference Akira S, Uematsu S, Takeuchi O: Pathogen recognition and innate immunity. Cell. 2006, 124: 783-801. 10.1016/j.cell.2006.02.015.CrossRefPubMed Akira S, Uematsu S, Takeuchi O: Pathogen recognition and innate immunity. Cell. 2006, 124: 783-801. 10.1016/j.cell.2006.02.015.CrossRefPubMed
9.
go back to reference Alter G, Suscovich TJ, Teigen N, Meier A, Streeck H, Brander C, Altfeld M: Single-stranded RNA derived from HIV-1 serves as a potent activator of NK cells. J Immunol. 2007, 178: 7658-7666.CrossRefPubMed Alter G, Suscovich TJ, Teigen N, Meier A, Streeck H, Brander C, Altfeld M: Single-stranded RNA derived from HIV-1 serves as a potent activator of NK cells. J Immunol. 2007, 178: 7658-7666.CrossRefPubMed
10.
go back to reference Song Y, Zhuang Y, Zhai S, Huang D, Zhang Y, Kang W, Li X, Liu Q, Yu Q, Sun Y: Increased expression of TLR7 in CD8(+) T cells leads to TLR7-mediated activation and accessory cell-dependent IFN-gamma production in HIV type 1 infection. AIDS research and human retroviruses. 2009, 25: 1287-1295. 10.1089/aid.2008.0303.CrossRefPubMed Song Y, Zhuang Y, Zhai S, Huang D, Zhang Y, Kang W, Li X, Liu Q, Yu Q, Sun Y: Increased expression of TLR7 in CD8(+) T cells leads to TLR7-mediated activation and accessory cell-dependent IFN-gamma production in HIV type 1 infection. AIDS research and human retroviruses. 2009, 25: 1287-1295. 10.1089/aid.2008.0303.CrossRefPubMed
11.
go back to reference Oh DY, Baumann K, Hamouda O, Eckert JK, Neumann K, Kucherer C, Bartmeyer B, Poggensee G, Oh N, Pruss A, et al: A frequent functional toll-like receptor 7 polymorphism is associated with accelerated HIV-1 disease progression. AIDS (London, England). 2009, 23: 297-307. 10.1097/QAD.0b013e32831fb540.CrossRef Oh DY, Baumann K, Hamouda O, Eckert JK, Neumann K, Kucherer C, Bartmeyer B, Poggensee G, Oh N, Pruss A, et al: A frequent functional toll-like receptor 7 polymorphism is associated with accelerated HIV-1 disease progression. AIDS (London, England). 2009, 23: 297-307. 10.1097/QAD.0b013e32831fb540.CrossRef
12.
go back to reference Diebold SS, Kaisho T, Hemmi H, Akira S, Reis e Sousa C: Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science (New York, NY). 2004, 303: 1529-1531. 10.1126/science.1093616.CrossRef Diebold SS, Kaisho T, Hemmi H, Akira S, Reis e Sousa C: Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science (New York, NY). 2004, 303: 1529-1531. 10.1126/science.1093616.CrossRef
13.
go back to reference Heil F, Hemmi H, Hochrein H, Ampenberger F, Kirschning C, Akira S, Lipford G, Wagner H, Bauer S: Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science (New York, NY). 2004, 303: 1526-1529. 10.1126/science.1093620.CrossRef Heil F, Hemmi H, Hochrein H, Ampenberger F, Kirschning C, Akira S, Lipford G, Wagner H, Bauer S: Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science (New York, NY). 2004, 303: 1526-1529. 10.1126/science.1093620.CrossRef
14.
15.
go back to reference Bekeredjian-Ding I, Roth SI, Gilles S, Giese T, Ablasser A, Hornung V, Endres S, Hartmann G: T cell-independent, TLR-induced IL-12p70 production in primary human monocytes. J Immunol. 2006, 176: 7438-7446.CrossRefPubMed Bekeredjian-Ding I, Roth SI, Gilles S, Giese T, Ablasser A, Hornung V, Endres S, Hartmann G: T cell-independent, TLR-induced IL-12p70 production in primary human monocytes. J Immunol. 2006, 176: 7438-7446.CrossRefPubMed
16.
go back to reference Bonizzi G, Karin M: The two NF-kappaB activation pathways and their role in innate and adaptive immunity. Trends Immunol. 2004, 25: 280-288. 10.1016/j.it.2004.03.008.CrossRefPubMed Bonizzi G, Karin M: The two NF-kappaB activation pathways and their role in innate and adaptive immunity. Trends Immunol. 2004, 25: 280-288. 10.1016/j.it.2004.03.008.CrossRefPubMed
17.
go back to reference Hartmann G, Krieg AM: CpG DNA and LPS induce distinct patterns of activation in human monocytes. Gene Therapy. 1999, 6: 893-903. 10.1038/sj.gt.3300880.CrossRefPubMed Hartmann G, Krieg AM: CpG DNA and LPS induce distinct patterns of activation in human monocytes. Gene Therapy. 1999, 6: 893-903. 10.1038/sj.gt.3300880.CrossRefPubMed
18.
go back to reference Ellery PJ, Tippett E, Chiu YL, Paukovics G, Cameron PU, Solomon A, Lewin SR, Gorry PR, Jaworowski A, Greene WC, et al: The CD16+ monocyte subset is more permissive to infection and preferentially harbors HIV-1 in vivo. J Immunol. 2007, 178: 6581-6589.CrossRefPubMed Ellery PJ, Tippett E, Chiu YL, Paukovics G, Cameron PU, Solomon A, Lewin SR, Gorry PR, Jaworowski A, Greene WC, et al: The CD16+ monocyte subset is more permissive to infection and preferentially harbors HIV-1 in vivo. J Immunol. 2007, 178: 6581-6589.CrossRefPubMed
19.
go back to reference Jurk M, Heil F, Vollmer J, Schetter C, Krieg AM, Wagner H, Lipford G, Bauer S: Human TLR7 or TLR8 independently confer responsiveness to the antiviral compound R-848. Nat Immunol. 2002, 3: 499-CrossRefPubMed Jurk M, Heil F, Vollmer J, Schetter C, Krieg AM, Wagner H, Lipford G, Bauer S: Human TLR7 or TLR8 independently confer responsiveness to the antiviral compound R-848. Nat Immunol. 2002, 3: 499-CrossRefPubMed
20.
go back to reference Zhu T, Muthui D, Holte S, Nickle D, Feng F, Brodie S, Hwangbo Y, Mullins JI, Corey L: Evidence for human immunodeficiency virus type 1 replication in vivo in CD14(+) monocytes and its potential role as a source of virus in patients on highly active antiretroviral therapy. J Virol. 2002, 76: 707-716. 10.1128/JVI.76.2.707-716.2002.CrossRefPubMedPubMedCentral Zhu T, Muthui D, Holte S, Nickle D, Feng F, Brodie S, Hwangbo Y, Mullins JI, Corey L: Evidence for human immunodeficiency virus type 1 replication in vivo in CD14(+) monocytes and its potential role as a source of virus in patients on highly active antiretroviral therapy. J Virol. 2002, 76: 707-716. 10.1128/JVI.76.2.707-716.2002.CrossRefPubMedPubMedCentral
21.
go back to reference Perry CM, Lamb HM: Topical imiquimod: a review of its use in genital warts. Drugs. 1999, 58: 375-390. 10.2165/00003495-199958020-00017.CrossRefPubMed Perry CM, Lamb HM: Topical imiquimod: a review of its use in genital warts. Drugs. 1999, 58: 375-390. 10.2165/00003495-199958020-00017.CrossRefPubMed
22.
go back to reference Gibson SJ, Imbertson LM, Wagner TL, Testerman TL, Reiter MJ, Miller RL, Tomai MA: Cellular requirements for cytokine production in response to the immunomodulators imiquimod and S-27609. J Interferon Cytokine Res. 1995, 15: 537-545. 10.1089/jir.1995.15.537.CrossRefPubMed Gibson SJ, Imbertson LM, Wagner TL, Testerman TL, Reiter MJ, Miller RL, Tomai MA: Cellular requirements for cytokine production in response to the immunomodulators imiquimod and S-27609. J Interferon Cytokine Res. 1995, 15: 537-545. 10.1089/jir.1995.15.537.CrossRefPubMed
23.
go back to reference Pockros PJ, Guyader D, Patton H, Tong MJ, Wright T, McHutchison JG, Meng TC: Oral resiquimod in chronic HCV infection: safety and efficacy in 2 placebo-controlled, double-blind phase IIa studies. J Hepatol. 2007, 47: 174-182. 10.1016/j.jhep.2007.02.025.CrossRefPubMed Pockros PJ, Guyader D, Patton H, Tong MJ, Wright T, McHutchison JG, Meng TC: Oral resiquimod in chronic HCV infection: safety and efficacy in 2 placebo-controlled, double-blind phase IIa studies. J Hepatol. 2007, 47: 174-182. 10.1016/j.jhep.2007.02.025.CrossRefPubMed
24.
go back to reference Schlaepfer E, Audige A, Joller H, Speck RF: TLR7/8 triggering exerts opposing effects in acute versus latent HIV infection. J Immunol. 2006, 176: 2888-2895.CrossRefPubMed Schlaepfer E, Audige A, Joller H, Speck RF: TLR7/8 triggering exerts opposing effects in acute versus latent HIV infection. J Immunol. 2006, 176: 2888-2895.CrossRefPubMed
25.
go back to reference Mikovits JA, Lohrey NC, Schulof R, Courtless J, Ruscetti FW: Activation of infectious virus from latent human immunodeficiency virus infection of monocytes in vivo. J Clin Invest. 1992, 90: 1486-1491. 10.1172/JCI116016.CrossRefPubMedPubMedCentral Mikovits JA, Lohrey NC, Schulof R, Courtless J, Ruscetti FW: Activation of infectious virus from latent human immunodeficiency virus infection of monocytes in vivo. J Clin Invest. 1992, 90: 1486-1491. 10.1172/JCI116016.CrossRefPubMedPubMedCentral
26.
go back to reference Sonza S, Mutimer HP, Oelrichs R, Jardine D, Harvey K, Dunne A, Purcell DF, Birch C, Crowe SM: Monocytes harbour replication-competent, non-latent HIV-1 in patients on highly active antiretroviral therapy. AIDS (London, England). 2001, 15: 17-22. 10.1097/00002030-200101050-00005.CrossRef Sonza S, Mutimer HP, Oelrichs R, Jardine D, Harvey K, Dunne A, Purcell DF, Birch C, Crowe SM: Monocytes harbour replication-competent, non-latent HIV-1 in patients on highly active antiretroviral therapy. AIDS (London, England). 2001, 15: 17-22. 10.1097/00002030-200101050-00005.CrossRef
27.
go back to reference Almodovar S, Del CCM, Maldonado IM, Villafane R, Abreu S, Melendez I, Dominguez C, Cuevas W, Collins TM, Lorenzo E: HIV-1 infection of monocytes is directly related to the success of HAART. Virology. 2007, 369: 35-46. 10.1016/j.virol.2007.07.010.CrossRefPubMed Almodovar S, Del CCM, Maldonado IM, Villafane R, Abreu S, Melendez I, Dominguez C, Cuevas W, Collins TM, Lorenzo E: HIV-1 infection of monocytes is directly related to the success of HAART. Virology. 2007, 369: 35-46. 10.1016/j.virol.2007.07.010.CrossRefPubMed
28.
go back to reference Naif HM, Li S, Alali M, Chang J, Mayne C, Sullivan J, Cunningham AL: Definition of the stage of host cell genetic restriction of replication of human immunodeficiency virus type 1 in monocytes and monocyte-derived macrophages by using twins. J Virol. 1999, 73: 4866-4881.PubMedPubMedCentral Naif HM, Li S, Alali M, Chang J, Mayne C, Sullivan J, Cunningham AL: Definition of the stage of host cell genetic restriction of replication of human immunodeficiency virus type 1 in monocytes and monocyte-derived macrophages by using twins. J Virol. 1999, 73: 4866-4881.PubMedPubMedCentral
29.
go back to reference Triques K, Stevenson M: Characterization of restrictions to human immunodeficiency virus type 1 infection of monocytes. J Virol. 2004, 78: 5523-5527. 10.1128/JVI.78.10.5523-5527.2004.CrossRefPubMedPubMedCentral Triques K, Stevenson M: Characterization of restrictions to human immunodeficiency virus type 1 infection of monocytes. J Virol. 2004, 78: 5523-5527. 10.1128/JVI.78.10.5523-5527.2004.CrossRefPubMedPubMedCentral
30.
go back to reference Lambotte O, Taoufik Y, de Goer MG, Wallon C, Goujard C, Delfraissy JF: Detection of infectious HIV in circulating monocytes from patients on prolonged highly active antiretroviral therapy. J Acquired Immune Deficiency Syndromes (1999). 2000, 23: 114-119.CrossRef Lambotte O, Taoufik Y, de Goer MG, Wallon C, Goujard C, Delfraissy JF: Detection of infectious HIV in circulating monocytes from patients on prolonged highly active antiretroviral therapy. J Acquired Immune Deficiency Syndromes (1999). 2000, 23: 114-119.CrossRef
31.
go back to reference Koyama S, Ishii KJ, Kumar H, Tanimoto T, Coban C, Uematsu S, Kawai T, Akira S: Differential role of TLR- and RLR-signaling in the immune responses to influenza A virus infection and vaccination. J Immunol. 2007, 179: 4711-4720.CrossRefPubMed Koyama S, Ishii KJ, Kumar H, Tanimoto T, Coban C, Uematsu S, Kawai T, Akira S: Differential role of TLR- and RLR-signaling in the immune responses to influenza A virus infection and vaccination. J Immunol. 2007, 179: 4711-4720.CrossRefPubMed
32.
go back to reference Reis e Sousa C: Activation of dendritic cells: translating innate into adaptive immunity. Current Opin Immunol. 2004, 16: 21-25. 10.1016/j.coi.2003.11.007.CrossRef Reis e Sousa C: Activation of dendritic cells: translating innate into adaptive immunity. Current Opin Immunol. 2004, 16: 21-25. 10.1016/j.coi.2003.11.007.CrossRef
33.
go back to reference Iwasaki A, Medzhitov R: Toll-like receptor control of the adaptive immune responses. Nat Immunol. 2004, 5: 987-995. 10.1038/ni1112.CrossRefPubMed Iwasaki A, Medzhitov R: Toll-like receptor control of the adaptive immune responses. Nat Immunol. 2004, 5: 987-995. 10.1038/ni1112.CrossRefPubMed
34.
go back to reference Aukrust P, Muller F, Lien E, Nordoy I, Liabakk NB, Kvale D, Espevik T, Froland SS: Tumor necrosis factor (TNF) system levels in human immunodeficiency virus-infected patients during highly active antiretroviral therapy: persistent TNF activation is associated with virologic and immunologic treatment failure. J Infect Dis. 1999, 179: 74-82. 10.1086/314572.CrossRefPubMed Aukrust P, Muller F, Lien E, Nordoy I, Liabakk NB, Kvale D, Espevik T, Froland SS: Tumor necrosis factor (TNF) system levels in human immunodeficiency virus-infected patients during highly active antiretroviral therapy: persistent TNF activation is associated with virologic and immunologic treatment failure. J Infect Dis. 1999, 179: 74-82. 10.1086/314572.CrossRefPubMed
35.
go back to reference Kedzierska K, Crowe SM: Cytokines and HIV-1: interactions and clinical implications. Antivir Chem Chemother. 2001, 12: 133-150.CrossRefPubMed Kedzierska K, Crowe SM: Cytokines and HIV-1: interactions and clinical implications. Antivir Chem Chemother. 2001, 12: 133-150.CrossRefPubMed
36.
go back to reference Khanna KV, Yu XF, Ford DH, Ratner L, Hildreth JK, Markham RB: Differences among HIV-1 variants in their ability to elicit secretion of TNF-alpha. J Immunol. 2000, 164: 1408-1415.CrossRefPubMed Khanna KV, Yu XF, Ford DH, Ratner L, Hildreth JK, Markham RB: Differences among HIV-1 variants in their ability to elicit secretion of TNF-alpha. J Immunol. 2000, 164: 1408-1415.CrossRefPubMed
37.
go back to reference Bergamini A, Faggioli E, Bolacchi F, Gessani S, Cappannoli L, Uccella I, Demin F, Capozzi M, Cicconi R, Placido R, et al: Enhanced production of tumor necrosis factor-alpha and interleukin-6 due to prolonged response to lipopolysaccharide in human macrophages infected in vitro with human immunodeficiency virus type 1. J Infect Dis. 1999, 179: 832-842. 10.1086/314662.CrossRefPubMed Bergamini A, Faggioli E, Bolacchi F, Gessani S, Cappannoli L, Uccella I, Demin F, Capozzi M, Cicconi R, Placido R, et al: Enhanced production of tumor necrosis factor-alpha and interleukin-6 due to prolonged response to lipopolysaccharide in human macrophages infected in vitro with human immunodeficiency virus type 1. J Infect Dis. 1999, 179: 832-842. 10.1086/314662.CrossRefPubMed
38.
go back to reference Rimaniol AC, Boussin FD, Dormont D, Bach JF, Zavala F: Mechanisms of downmodulation and release of tumour necrosis factor receptor induced by human immunodeficiency virus type 1 in human monocytes. Cytokine. 1997, 9: 9-18. 10.1006/cyto.1996.0130.CrossRefPubMed Rimaniol AC, Boussin FD, Dormont D, Bach JF, Zavala F: Mechanisms of downmodulation and release of tumour necrosis factor receptor induced by human immunodeficiency virus type 1 in human monocytes. Cytokine. 1997, 9: 9-18. 10.1006/cyto.1996.0130.CrossRefPubMed
39.
go back to reference Merrill JE, Koyanagi Y, Chen IS: Interleukin-1 and tumor necrosis factor alpha can be induced from mononuclear phagocytes by human immunodeficiency virus type 1 binding to the CD4 receptor. J Virol. 1989, 63: 4404-4408.PubMedPubMedCentral Merrill JE, Koyanagi Y, Chen IS: Interleukin-1 and tumor necrosis factor alpha can be induced from mononuclear phagocytes by human immunodeficiency virus type 1 binding to the CD4 receptor. J Virol. 1989, 63: 4404-4408.PubMedPubMedCentral
40.
go back to reference Zembala M, Pryjma J, Plucienniczak A, Szczepanek A, Jasinski M, Ruggiero I, Piselli P, Colizzi V: Interaction of HIV-1 gp120 molecule fragments with human monocytes: different requirements for tumor necrosis factor-alpha and IL-6 production. Clin Immunol Immunopathol. 1995, 75: 131-139. 10.1006/clin.1995.1062.CrossRefPubMed Zembala M, Pryjma J, Plucienniczak A, Szczepanek A, Jasinski M, Ruggiero I, Piselli P, Colizzi V: Interaction of HIV-1 gp120 molecule fragments with human monocytes: different requirements for tumor necrosis factor-alpha and IL-6 production. Clin Immunol Immunopathol. 1995, 75: 131-139. 10.1006/clin.1995.1062.CrossRefPubMed
41.
go back to reference Catalfamo M, Di Mascio M, Hu Z, Srinivasula S, Thaker V, Adelsberger J, Rupert A, Baseler M, Tagaya Y, Roby G, et al: HIV infection-associated immune activation occurs by two distinct pathways that differentially affect CD4 and CD8 T cells. Proc Natl Acad Sci USA. 2008, 105: 19851-19856. 10.1073/pnas.0810032105.CrossRefPubMedPubMedCentral Catalfamo M, Di Mascio M, Hu Z, Srinivasula S, Thaker V, Adelsberger J, Rupert A, Baseler M, Tagaya Y, Roby G, et al: HIV infection-associated immune activation occurs by two distinct pathways that differentially affect CD4 and CD8 T cells. Proc Natl Acad Sci USA. 2008, 105: 19851-19856. 10.1073/pnas.0810032105.CrossRefPubMedPubMedCentral
42.
go back to reference Innocenti P, Ottmann M, Morand P, Leclercq P, Seigneurin JM: HIV-1 in blood monocytes: frequency of detection of proviral DNA using PCR and comparison with the total CD4 count. AIDS Res Human Retroviruses. 1992, 8: 261-268. 10.1089/aid.1992.8.261.CrossRef Innocenti P, Ottmann M, Morand P, Leclercq P, Seigneurin JM: HIV-1 in blood monocytes: frequency of detection of proviral DNA using PCR and comparison with the total CD4 count. AIDS Res Human Retroviruses. 1992, 8: 261-268. 10.1089/aid.1992.8.261.CrossRef
43.
go back to reference Hart OM, Athie-Morales V, O'Connor GM, Gardiner CM: TLR7/8-mediated activation of human NK cells results in accessory cell-dependent IFN-gamma production. J Immunol. 2005, 175: 1636-1642.CrossRefPubMed Hart OM, Athie-Morales V, O'Connor GM, Gardiner CM: TLR7/8-mediated activation of human NK cells results in accessory cell-dependent IFN-gamma production. J Immunol. 2005, 175: 1636-1642.CrossRefPubMed
44.
go back to reference Akira S, Takeda K: Toll-like receptor signalling. Nat Reviews. 2004, 4: 499-511.CrossRef Akira S, Takeda K: Toll-like receptor signalling. Nat Reviews. 2004, 4: 499-511.CrossRef
45.
go back to reference Miettinen M, Sareneva T, Julkunen I, Matikainen S: IFNs activate toll-like receptor gene expression in viral infections. Genes and Immunity. 2001, 2: 349-355. 10.1038/sj.gene.6363791.CrossRefPubMed Miettinen M, Sareneva T, Julkunen I, Matikainen S: IFNs activate toll-like receptor gene expression in viral infections. Genes and Immunity. 2001, 2: 349-355. 10.1038/sj.gene.6363791.CrossRefPubMed
46.
go back to reference Grossman Z, Meier-Schellersheim M, Paul WE, Picker LJ: Pathogenesis of HIV infection: what the virus spares is as important as what it destroys. Nat Med. 2006, 12: 289-295. 10.1038/nm1380.CrossRefPubMed Grossman Z, Meier-Schellersheim M, Paul WE, Picker LJ: Pathogenesis of HIV infection: what the virus spares is as important as what it destroys. Nat Med. 2006, 12: 289-295. 10.1038/nm1380.CrossRefPubMed
47.
go back to reference Lester RT, Yao XD, Ball TB, McKinnon LR, Kaul R, Wachihi C, Jaoko W, Plummer FA, Rosenthal KL: Toll-like receptor expression and responsiveness are increased in viraemic HIV-1 infection. AIDS (London, England). 2008, 22: 685-694. 10.1097/QAD.0b013e3282f4de35.CrossRef Lester RT, Yao XD, Ball TB, McKinnon LR, Kaul R, Wachihi C, Jaoko W, Plummer FA, Rosenthal KL: Toll-like receptor expression and responsiveness are increased in viraemic HIV-1 infection. AIDS (London, England). 2008, 22: 685-694. 10.1097/QAD.0b013e3282f4de35.CrossRef
Metadata
Title
R-848 triggers the expression of TLR7/8 and suppresses HIV replication in monocytes
Authors
Hua Nian
Wen-Qing Geng
Hua-Lu Cui
Ming-jia Bao
Zi-ning Zhang
Min Zhang
Ying Pan
Qing-Hai Hu
Hong Shang
Publication date
01-12-2012
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2012
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/1471-2334-12-5

Other articles of this Issue 1/2012

BMC Infectious Diseases 1/2012 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.